Jazz Pharmaceuticals director granted 1,605 stock units

Smith Mark Douglas reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Smith Mark Douglas reported acquisition or exercise transactions in this Form 4 filing.

Jazz Pharmaceuticals director Mark Douglas Smith reported an equity compensation grant of 1,605 restricted stock units, each representing a right to receive one ordinary share. The award was made at $0.0000 per share under the 2007 Amended and Restated Non-Employee Directors Stock Award Plan and will vest in full on July 23, 2027, subject to continuous service and other conditions. Following this grant, Smith directly holds 11,285 ordinary shares.

Insider Trade Summary

Grant/Award: 1,605 shares

Grant/Award 1 txn

Insider Smith Mark Douglas

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 11,285 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

Restricted stock units granted: 1605.0000 shares Price per unit: 0.0000 Shares held after transaction: 11285.0000 shares +2 more

5 metrics

Restricted stock units granted 1605.0000 shares Equity award to director Mark Douglas Smith on 2026-08-05

Price per unit 0.0000 Reported grant price per restricted stock unit

Shares held after transaction 11285.0000 shares Total ordinary shares directly held by Smith following the award

Vesting date July 23, 2027 Restricted stock units vest in full on this date, subject to conditions

Acquisition transactions in filing 1 Number of acquisition-type transactions reported in this Form 4

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary"

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional"

Non-Employee Directors Stock Award Plan financial

"Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Jazz Pharmaceuticals (JAZZ) director Mark Douglas Smith report in this Form 4?

Mark Douglas Smith reported receiving an equity grant of 1,605 restricted stock units linked to Jazz Pharmaceuticals ordinary shares. The grant vests fully on July 23, 2027, subject to continuous service, and brings his direct holdings to 11,285 ordinary shares after the award.

How many units did Mark Douglas Smith effectively acquire in the JAZZ transaction and at what price?

Smith was granted 1,605 restricted stock units, each representing a right to receive one ordinary share, at a reported price of $0.0000 per unit. This reflects a compensation award rather than an open-market purchase, increasing his reported direct stake in Jazz Pharmaceuticals.

When do the restricted stock units reported by Jazz Pharmaceuticals (JAZZ) vest?

The reported 1,605 restricted stock units are scheduled to vest in full on July 23, 2027. Vesting is contingent on the reporting person’s continuous service with Jazz Pharmaceuticals and satisfaction of certain additional conditions described in the equity award’s terms.

Under which plan were the JAZZ restricted stock units granted to Mark Douglas Smith?

The 1,605 restricted stock units were granted under Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each unit represents a contingent right to receive one ordinary share upon vesting, aligning director compensation with the company’s equity performance over time.

Was the JAZZ Form 4 transaction made under a Rule 10b5-1 trading plan?

The filing indicates the transaction was not made under a Rule 10b5-1 trading plan, as the related checkbox was not affirmed. The reported activity is an equity compensation grant of restricted stock units rather than a discretionary market trade under a preset trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 05:46 PM Accepted by SEC EDGAR 08/07/2026 - 05:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Mark Douglas

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		A(1)		1,605	A	$0.0	11,285	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Mark D. Smith	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)